Stress ulcer prophylaxis guidelines: Are they being implemented in Lebanese health care centers?

Table 5 Assessment of stress ulcer prophylaxis practice per indication n (%)

SUP variable	Candidates	Non-candidates	P-value
Acid-suppressant drugs
PPIs	208 (62.8)	410 (60.9)
H2-RAs	123 (37.2)	263 (39.1)	0.557
Dose
Appropriate	281 (84.9)	610 (90.0)
Inappropriate	50 (15.1)	61 (9.1)	0.004
Route
Appropriate	150 (45.3)	301 (44.7)
Inappropriate	181 (54.7)	372 (55.3)	0.859
Dose and route
Appropriate	124 (37.5)	265 (39.4)
Inappropriate	207 (62.5)	408 (60.6)	0.558
Duration (d)
Median (IQR)	5.0 (7.0)	3.0 (4.0)	< 0.0011
Discharge on SUP
Yes	49 (28.8)	70 (20.9)
No	121 (71.2)	265 (79.1)	0.047

¹P-value derived using the Mann-Whitney U test; P-value remained significant even after controlling for hospital stay. SUP: Stress ulcer prophylaxis; PPIs: Proton pump inhibitors; H2-RAs: Histamine 2 receptors antagonists; IQR: Interquartile range.